Search Results

Telomerase-specific virotherapy for human squamous cell carcinoma

Author: Fujiwara, Toshiyoshi

Source: Expert Opinion on Biological Therapy, Volume 9, Number 3, March 2009 , pp. 321-329(9)

Publisher: Informa Healthcare

Establishment of biological and pharmacokinetic assays of telomerase-specific replication-selective adenovirus

Authors: Hashimoto, Yuuri; Watanabe, Yuichi; Shirakiya, Yoshiko; Uno, Futoshi; Kagawa, Shunsuke; Kawamura, Hitoshi; Nagai, Katsuyuki; Tanaka, Noriaki; Kumon, Horomi; Urata, Yasuo; Fujiwara, Toshiyoshi

Source: Cancer Science, Volume 99, Number 2, February 2008 , pp. 385-390(6)

Publisher: Blackwell Publishing

Telomerase-Specific Oncolytic Virotherapy for Human Cancer with the hTERT Promoter

Authors: Fujiwara, Toshiyoshi; Urata, Yasuo; Tanaka, Noriaki

Source: Current Cancer Drug Targets, Volume 7, Number 2, March 2007 , pp. 191-201(11)

Publisher: Bentham Science Publishers

Oncolytic virotherapy for nasopharyngeal cancer

Authors: Bapat, U.; Wang, Y.; Alusi, G.; Chisholm, E.; Francis, J.; Hallden, G.; Lemoine, N.

Source: Clinical Otolaryngology, Volume 31, Number 6, December 2006 , pp. 582-583(2)

Publisher: Blackwell Publishing

Viral Vectors for Gene-Directed Enzyme Prodrug Therapy

Authors: Schepelmann, Silke; Springer, Caroline J.

Source: Current Gene Therapy, Volume 6, Number 6, December 2006 , pp. 647-670(24)

Publisher: Bentham Science Publishers

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

Authors: Steve H Thorne; David H Kirn

Source: Expert Opinion on Biological Therapy, Volume 4, Number 8, 1 August 2004 , pp. 1307-1321(15)

Publisher: Informa Healthcare

Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research

Author: Emil Lou

Source: Annals of Medicine, Volume 36, Number 1, 2004 , pp. 2-8(7)

Publisher: Informa Healthcare

Engineering Regulatory Elements for Conditionally-Replicative Adenoviruses

Authors: Haviv, Yosef S.; Curiel, David T.

Source: Current Gene Therapy, Volume 3, Number 4, August 2003 , pp. 357-385(29)

Publisher: Bentham Science Publishers

Oncolytic biotherapy: a novel therapeutic platform

Authors: Hawkins L.K.; Lemoine N.R.; Kirn D.

Source: Lancet Oncology, Volume 3, Number 1, 1 January 2002 , pp. 17-26(10)

Publisher: Elsevier

Systemic administration of replication-selective adenoviruses

Author: Kirn D.

Source: European Journal of Cancer, Volume 37, Supplement 3, September 2001 , pp. 65-65(1)

Publisher: Elsevier

Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of Phase I and II trials

Author: Kirn D.

Source: Expert Opinion on Biological Therapy, Volume 1, Number 3, May 2001 , pp. 525-538(14)

Publisher: Informa Healthcare

Effect of Preexisting Anti-Herpes Immunity on the Efficacy of Herpes Simplex Viral Therapy in a Murine Intraperitoneal Tumor Model

Authors: Lambright E.S.; Kang E.H.; Force S.; Lanuti M.; Caparrelli D.; Kaiser L.R.; Albelda S.M.; Molnar-Kimber K.L.

Source: Molecular Therapy, Volume 2, Number 4, October 2000 , pp. 387-393(7)

Publisher: Elsevier

Effect of Preexisting Anti-Herpes Immunity on the Efficacy of Herpes Simplex Viral Therapy in a Murine Intraperitoneal Tumor Model

Authors: Lambright E.S.; Kang E.H.; Force S.; Lanuti M.; Caparrelli D.; Kaiser L.R.; Albelda S.M.; Molnar-Kimber K.L.

Source: Molecular Therapy, Volume 2, Number 4, October 2000 , pp. 387-393(7)

Publisher: Academic Press